// App-Quantinova.ai

736 : Hypoxia-induced EGFR tyrosine kinase inhibitor resistance is associated with epithelial-mesenchymal transition in NSCLC

Researchers

Presenter

  • Yuhong Lu

Principal Investigators

  • Peter M. Glazer

Medical Centers

  • Yale University School of Medicine, New Haven, CT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Solid malignancies

  • Lung Cancer

Biomarkers

  • BCL2 like 11

  • Cadherin 1

  • Epidermal growth factor receptor

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • gefitinib

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved